Free Trial

Microbot Medical (MBOT) Stock Price, News & Analysis

+0.02 (+1.89%)
(As of 07/12/2024 ET)
Today's Range
50-Day Range
52-Week Range
157,760 shs
Average Volume
174,667 shs
Market Capitalization
$17.25 million
P/E Ratio
Dividend Yield
Price Target

Microbot Medical MarketRank™ Stock Analysis

Analyst Rating
3.00 Rating Score
548.1% Upside
$7.00 Price Target
Short Interest
1.90% of Shares Sold Short
Dividend Strength
News Sentiment
0.81mentions of Microbot Medical in the last 14 days
Based on 5 Articles This Week
Insider Trading
Proj. Earnings Growth
From ($0.66) to ($0.52) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.61 out of 5 stars

Medical Sector

442nd out of 912 stocks

Surgical & Medical Instruments Industry

52nd out of 100 stocks

MBOT stock logo

About Microbot Medical Stock (NASDAQ:MBOT)

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.

MBOT Stock Price History

MBOT Stock News Headlines

Short Interest in Microbot Medical Inc. (NASDAQ:MBOT) Drops By 18.9%
Man who Predicted Trump 2016 Win: “Prepare for Election Meltdown”
Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… A predicted Trump would win. You won’t believe what he’s predicting now.
Man who Predicted Trump 2016 Win: “Prepare for Election Meltdown”
Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… A predicted Trump would win. You won’t believe what he’s predicting now.
See More Headlines
Receive MBOT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Microbot Medical and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
Next Earnings (Estimated)
Fiscal Year End

Industry, Sector and Symbol

Surgical & medical instruments
Current Symbol
Year Founded

Price Target and Rating

Average Stock Price Target
High Stock Price Target
Low Stock Price Target
Potential Upside/Downside
Consensus Rating
Rating Score (0-4)
Research Coverage
1 Analysts


Net Income
Pretax Margin


Sales & Book Value

Annual Sales
Book Value
$0.38 per share


Free Float
Market Cap
$17.25 million

Social Links

Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Mr. Harel Gadot (Age 51)
    Co-Founder, President, CEO & Chairman
    Comp: $813.82k
  • Mr. Yoseph Bornstein (Age 65)
    Co-Founder & Independent Director
    Comp: $13.12k
  • Ms. Rachel Vaknin (Age 44)
    Chief Financial Officer
    Comp: $212.97k
  • Dr. Simon Sharon MBA (Age 63)
    MSc, CTO & GM of Microbot Israel
    Comp: $381.51k
  • Dr. Juan Diaz-Cartelle (Age 48)
    Chief Medical Officer

MBOT Stock Analysis - Frequently Asked Questions

How have MBOT shares performed this year?

Microbot Medical's stock was trading at $1.64 at the beginning of 2024. Since then, MBOT shares have decreased by 34.1% and is now trading at $1.08.
View the best growth stocks for 2024 here

How were Microbot Medical's earnings last quarter?

Microbot Medical Inc. (NASDAQ:MBOT) released its earnings results on Wednesday, May, 15th. The biotechnology company reported ($0.17) earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of ($0.17).

When did Microbot Medical's stock split?

Shares of Microbot Medical reverse split before market open on Monday, May 9th 2016. The 1-12 reverse split was announced on Friday, May 6th 2016. The number of shares owned by shareholders was adjusted after the closing bell on Friday, May 6th 2016. An investor that had 100 shares of stock prior to the reverse split would have 8 shares after the split.

How do I buy shares of Microbot Medical?

Shares of MBOT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Microbot Medical own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Microbot Medical investors own include Advanced Micro Devices (AMD), Athersys (ATHX), NVIDIA (NVDA), Gilead Sciences (GILD), Inovio Pharmaceuticals (INO) and Novavax (NVAX).

This page (NASDAQ:MBOT) was last updated on 7/14/2024 by Staff

From Our Partners